Regenxbio
Price & Volume
Stats
See more52W Range | $5.03-$12.22 |
Market Cap | $487.4M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $155.7M |
Revenue Growth (YoY) | -4.2% |
Gross Profit (12 Mos) | $128.4M |
Diluted EPS | -$3.44 |
News
See moreYahoo Finance • 27 days ago
REGENXBIO Reports Positive Data From Phase I/II/III CAMPSIITE Trial Of RGX-121
Yahoo Finance • 2 months ago
Sarepta Therapeutics’ SWOT analysis: stock faces challenges amid promising pipeline
Yahoo Finance • 2 months ago
REGENXBIO INC (NASDAQ:RGNX) Reports Q2 2025 Earnings Miss, Stock Slides Amid Revenue and EPS Shortfalls
Yahoo Finance • 2 months ago
REGENXBIO Reports Second Quarter 2025 Financial Results and Operational Highlights
About
CEO | Mr. Curran M. Simpson M.S. |
CFO | Mr. Mitchell Chan M.B.A. |
Address | 9804 Medical Center Drive, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 353 |
